European Clinical Trial Directive
EU attempt to harmonize US and EU clinical trial requirements and processes
Greatest impact on Phase I timelines
- Now requires CTA (IND equivalent) filing prior to clinical trial initiation
U.S. clients did not place trials in EU for 2H04
Business returning 1H05 to pre-directive levels
EU CTD will improve competitiveness for European clinical trials in Phase II-IV